Project Grant S10OD040108
- Federal Project Grant Award Summary The University of Michigan received a $149,264 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective March 26, 2026, with completion targeted for November 30, 2027. The award supports development of magnetic resonance (MR) fingerprinting technology specifically optimized for cardiac magnetic...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $651,349 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of May 31, 2029. This award funds research investigating stoichiometric, adhesion, and contractile deficits in desmoplakin cardiomyopathy, a condition caused by genetic...
- Federal Grant Award Summary The University of Michigan received a $1,494,562 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 20, 2025, with a completion date of June 30, 2030. The research initiative will develop an in situ micro-rheology technique utilizing ultrasound-responsive nanodroplets to characterize aging thrombi (blood clots) in real-time and non-invasively. The primary...
- Federal Grant Award Summary The University of Michigan received a $619,882 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) effective July 5, 2025, with completion targeted for April 30, 2030. The grant funds a mechanistic clinical trial designed to personalize heart failure treatment through genomic analysis. The research will prospectively validate a polygenic risk score (PRS) for predicting...
- Federal Grant Award Summary Michigan Technological University received a $589,998 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2028. The award supports research investigating cardiac sensory and sympathetic nerve dysregulation in hypertrophic cardiomyopathy (HCM), a genetic heart disease affecting approximately 1 in 500 individuals and representing the...
- Federal Project Grant Award Summary Michigan Technological University received a $383,801 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to develop advanced biosensing technology for clinical diagnostics. The award, effective May 1, 2026 through February 28, 2031, funds the development of a cost-effective, scalable, and multiplexed biosensing platform based on molecularly imprinted polymers...
- Federal Project Grant Award Summary The University of Michigan received a $304,007 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 18, 2025, with completion targeted for December 31, 2027. The project, "Leveraging a 'Sliding-Window' Type I CRISPR Base Editing Platform to Correct CFTR Null Mutations," delivers research and development services focused on advancing a novel gene-editing...
- Federal Project Grant Award Summary The National Science Foundation's Engineering program (CFDA 47.041) awarded $199,991 to the University of Michigan-Dearborn on May 15, 2026, through an Engineering Research Initiation (ERI) grant to develop a novel microphysiological system that models perivascular environments in the brain. The primary deliverable is an engineered device that replicates cerebrospinal fluid (CSF) flow dynamics and cellular conditions while enabling precise control over...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the Regents of the University of Michigan a Project Grant totaling $429,000 (awarded May 1, 2026, with completion targeted for March 1, 2028) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project develops an ultrasensitive bioassay platform utilizing a microlaser ensemble quenching detection method to overcome...
- Federal Grant Award Summary The University of Michigan has received a $424,264 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025 through May 31, 2030. This award supports the development of advanced quantitative analysis methodologies for long-read RNA-sequencing (RNA-seq) data at both bulk and single-cell dimensions. The research will advance understanding of gene...
The University of Michigan received a $148,085 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on May 15, 2026, with completion targeted for May 14, 2027. The award funds the acquisition of the CardioExcyte 96 system, an advanced impedance-based electrophysiology platform designed to enable high-throughput, non-invasive monitoring of cardiac cell activity in 96-well plate configurations. This label-free technology facilitates real-time measurement of key cardiac parameters including action potentials, contractility, and heart rate variability without requiring electrodes or fluorescent dyes. The CardioExcyte 96 system will be installed at the University of Michigan's Ann Arbor campus and integrated into existing research workflows to address critical gaps in cardiac research infrastructure. The technology supports multiple research objectives, including enhanced accuracy and throughput in cardiac drug screening, advancement of arrhythmia and cardiotoxicity studies, and cross-domain research collaboration. By providing high-resolution, real-time electrophysiological data, the system will strengthen the institution's research capabilities in cardiovascular disease modeling, drug-induced cardiotoxicity assessment, and personalized medicine applications, thereby accelerating discovery and innovation in cardiovascular therapeutics and biology.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $148.1k | 5/11/26 |